Search results for "Early detection"

showing 10 items of 222 documents

Applications of OralCDx ® methodology in the diagnosis of oral leukoplakia

2011

Objective: We aim to evaluate the effectiveness of the brush biopsy technique using OralCDx ® (OralScan Laboratories Inc., Suffern, NY) as a new method for early diagnosis and control of a “potentially malignant disorder” such as oral leukoplakia. Design of the study: We performed a study in which samples were taken using OralCDx ® on 24 patients who visited the Master of Oral Medicine, Oral Surgery and Implantology of the University of Santiago de Compostela between February 2009 and May 2010. These patients presented clinical and histological lesions that were consistent with oral leukoplakia. We evaluated the relationship between the keratinization degree of the lesions and cell represen…

Malemedicine.medical_specialtyBiopsyDentistryCytologyBiopsyOral and maxillofacial pathologyHumansMedicineSampling (medicine)General DentistryEarly Detection of CancerLeukoplakiaOral Medicine and PathologyKappa valuemedicine.diagnostic_testbusiness.industryMiddle Aged:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseDermatologyOral leukoplakiastomatognathic diseasesOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASResearch-ArticleFemaleSurgeryLeukoplakia OralbusinessOral medicine
researchProduct

Long-term effect of faecal occult blood screening on incidence and mortality from colorectal cancer

2014

Abstract Background Several randomized trials have shown a reduction of colorectal cancer mortality by screening using guaiac-based faecal occult blood tests. However, little is known on the long-term effect of screening at the population level in everyday practice. Methods Small-sized geographic areas including a total of 91,199 individuals were allocated to either biennal screening using the Hemoccult-II test or no screening. The expected mortality and incidence in the cohort invited to screening was determined using mortality and incidence in the non-screened population. Results Colorectal cancer mortality was significantly lower in the population invited to screening than in the non-scr…

Malemedicine.medical_specialtyColorectal cancerPopulationlaw.inventionRandomized controlled triallawInternal medicinemedicineHumansMass ScreeningTerm effecteducationEarly Detection of CancerMass screeningAgedGynecologyeducation.field_of_studyHepatologybusiness.industryIncidenceIncidence (epidemiology)GastroenterologyMiddle Agedmedicine.diseaseStandardized mortality ratioOccult BloodCohortFemaleFranceColorectal NeoplasmsbusinessFollow-Up StudiesDigestive and Liver Disease
researchProduct

Delay in the Diagnosis of Breast and Colorectal Cancer in People With Severe Mental Disorders

2020

Background People with severe mental disorders have a worse cancer prognosis, with higher mortality rates than the general population, and this could be partially attributed to a later detection. Breast cancer and colorectal cancer have mass population screenings in Spain, but the influence in early diagnosis is unknown in persons with severe mental disorders. Objective To compare the severity of breast and colorectal cancers at diagnosis in people with and without mental disorders. Methods This was an observational, retrospective, case-control study with 1:2 matching performed in Eastern Spain. Data were retrieved for analysis from electronic medical records. Results The study included 111…

Malemedicine.medical_specialtyDelayed DiagnosisColorectal cancerPopulationBreast NeoplasmsMental disordersColorectal neoplasms03 medical and health sciences0302 clinical medicineBreast cancerInternal medicineCancer screeningOdds RatioHumansMedicineeducationEarly Detection of CancerAgedRetrospective Studieseducation.field_of_study030504 nursingOncology (nursing)business.industryMental DisordersRetrospective cohort studyOdds ratioMiddle Agedmedicine.diseaseMental healthOncologySpainCase-Control StudiesEarly detection of cancer030220 oncology & carcinogenesisRelative riskNeoplasm stagingFemaleBreast neoplasmsColorectal Neoplasms0305 other medical sciencebusinessCancer Nursing
researchProduct

Editor's Choice – Occurrence and Classification of Proximal Type I Endoleaks After EndoVascular Aneurysm Sealing Using the Nellix™ Device

2017

Objective/Background Proximal type I endoleaks are associated with abdominal aortic aneurysm (AAA) growth and rupture and necessitate repair. The Nellix™ EndoVascular Aneurysm Sealing (EVAS) system is a unique approach to AAA repair, where the appearance and treatment of endoleaks is also different. This study aimed to analyse and categorise proximal endoleaks in an EVAS treated cohort. Methods All patients, treated from February 2013 to December 2015, in 15 experienced EVAS centres, presenting with proximal endoleak were included. Computed tomography scans were analysed by a core laboratory. A consensus meeting was organised to discuss and qualify each case for selection, technical aspects…

Malemedicine.medical_specialtyEndoleakmedicine.medical_treatmentTechnical successEarly detectionComputed tomography030204 cardiovascular system & hematology030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineAneurysmRisk FactorsHumansMedicineAgedRetrospective StudiesAged 80 and overmedicine.diagnostic_testbusiness.industryIncidenceIncidence (epidemiology)Endovascular ProceduresStentMiddle Agedmedicine.diseaseAbdominal aortic aneurysmSurgeryTreatment OutcomeFemaleSurgeryCore laboratoryCardiology and Cardiovascular MedicinebusinessAortic Aneurysm AbdominalEuropean Journal of Vascular and Endovascular Surgery
researchProduct

Does Family History of Cancer Influence Undergoing Screening and Gastrointestinal Investigations?

2020

Background and Aims: Although a family history of cancer (FHC) can modify the lifestyle and attitudes towards participation in cancer screening programs, studies on this relationship show mixed results and vary across populations. The objectives of the study were to compare sociodemographic characteristics, history of gastrointestinal (GI) investigations and Helicobacter pylori eradication, and modifiable cancer risk factors between those with FHC and those with no FHC (NFHC), and to investigate the association between FHC and a history of GI investigations.
 Methods: A total of 3,455 questionnaires from the pilot study of the “Helicobacter pylori eradication and pepsinogen testing for…

Malemedicine.medical_specialtyHealth BehaviorColonoscopyPilot ProjectsLogistic regressionHelicobacter InfectionsScreening programmeRisk FactorsInternal medicineSurveys and QuestionnairesCancer screeningmedicineHumanscardiovascular diseasesFamily historyMedical History TakingEarly Detection of CancerGastrointestinal Neoplasmsbiologymedicine.diagnostic_testHelicobacter pyloribusiness.industryGastroenterologyCancerFaecal occult bloodColonoscopyHelicobacter pyloriPatient Acceptance of Health Caremedicine.diseasebiology.organism_classificationLatviaSocioeconomic FactorsFemalebusinessJournal of gastrointestinal and liver diseases : JGLD
researchProduct

Breath testing: the future for digestive cancer detection.

2013

Malemedicine.medical_specialtyHepatologybusiness.industryGastroenterologyMEDLINEBreath testingDogsOdorantsmedicineAnimalsHumansFemaleIntensive care medicinebusinessColorectal NeoplasmsDigestive cancerEarly Detection of CancerExpert review of gastroenterologyhepatology
researchProduct

Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma.

2014

Lead-time is the time by which diagnosis is anticipated by screening/surveillance with respect to the symptomatic detection of a disease. Any screening program, including surveillance for hepatocellular carcinoma (HCC), is subject to lead-time bias. Data regarding lead-time for HCC are lacking. Aims of the present study were to calculate lead-time and to assess its impact on the benefit obtainable from the surveillance of cirrhotic patients. Background & Aims: Lead-time is the time by which diagnosis is anticipated by screening/surveillance with respect to the symptomatic detection of a disease. Any screening program, including surveillance for hepatocellular carcinoma (HCC), is subject to …

Malemedicine.medical_specialtyPediatricsCarcinoma HepatocellularTime FactorsHepatocellular carcinomaSettore MED/12 - GASTROENTEROLOGIADiseaseGastroenterologyBiasInternal medicineOverall survivalmedicineHumansEarly Detection of CancerAgedEstimationSurveillanceHepatologybusiness.industryLiver Neoplasmsmedicine.diseasedigestive system diseasesLead time biasCirrhosisHepatocellular carcinomaFemalebusinessLead-time biasFollow-Up Studies
researchProduct

Biological and prognostic differences between symptomatic colorectal carcinomas and those detected by screening

2019

REDISSEC-CARESS/CCR group.

Malemedicine.medical_specialtySurvivalColorectal cancerPerineural invasionAsymptomaticGastroenterology03 medical and health sciences0302 clinical medicineInternal medicineBiomarkers TumorHumansMass ScreeningMedicineProspective StudiesColorectal carcinomas030212 general & internal medicineStage (cooking)Prospective cohort studyEarly Detection of CancerAgedNeoplasm StagingBiological markersbusiness.industryIncidenceGeneral MedicineMiddle Agedmedicine.diseaseImmunohistochemistrySurvival RateOncologySpain030220 oncology & carcinogenesisCohortScreeningT-stageFemaleSurgerymedicine.symptomColorectal NeoplasmsbusinessBody mass indexFollow-Up StudiesEuropean Journal of Surgical Oncology
researchProduct

Potential Effect of Antiplatelet and Anticoagulant Therapy on the Timing of the Diagnosis of Bladder Cancer

2016

Abstract Background The most common presenting symptom of bladder cancer (BCa) is hematuria. The present study was designed to define whether patients taking antiplatelet and/or anticoagulant drugs might experience hematuria at an earlier stage or grade of BCa. Patients and Methods The data from 1532 consecutive patients who presented to the emergency unit of our institute from 2004 to 2012 because of gross hematuria as a single symptom were evaluated. Patients (n = 227) with a further diagnosis of BCa were included in our study. For the purpose of the present study, patients were divided into 2 groups: patients receiving antiplatelet or anticoagulant therapy (AAT) (group 1) and patients no…

Malemedicine.medical_specialtymedicine.drug_classUrology030232 urology & nephrologyLogistic regressionSettore MED/24 - Urologia03 medical and health sciences0302 clinical medicineRetrospective StudieInternal medicinemedicineHumansAntiplateletStage (cooking)Macroscopic hematuriaAnticoagulant; Antiplatelet; Bladder cancer; Emergency room; Hematuria; Non-muscle invasive bladder cancerEarly Detection of CancerRetrospective StudiesHematuriaAgedNeoplasm StagingBladder cancerbusiness.industryPlatelet Aggregation InhibitorAnticoagulantBladder cancerAnticoagulantAnticoagulantsRetrospective cohort studyEmergency roomOdds ratioMiddle Agedmedicine.diseaseSurgeryUrinary Bladder NeoplasmsOncology030220 oncology & carcinogenesisUrinary Bladder NeoplasmPlatelet aggregation inhibitorFemalebusinessNon-muscle invasive bladder cancerPlatelet Aggregation InhibitorsHuman
researchProduct

First results of cavity ring down signals from exhaled air

2017

In this paper we report first results from the developed cavity ring-down spectrometer for application in human breath analysis for the diagnostics of diabetes and later for early detection of lung cancer. Our cavity ring-down spectrometer works in UV region with pulsed Nd:YAG laser at 266 nm wavelength. First experiments allow us to determine acetone and benzene at the level bellow ppm. In our experiment, first results from breath samples from volunteers after doing different activities were collected and examined. Influence of the smoking on the breath signals also was examined.

Materials scienceSpectrometerAnalytical chemistryEarly detectionLaserExhaled airlaw.inventionCavity ring-down spectroscopychemistry.chemical_compoundBreath gas analysischemistrylawRing downBenzeneBiophotonics—Riga 2017
researchProduct